673 related articles for article (PubMed ID: 24700550)
1. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
2. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling.
Kido M; Watanabe N; Okazaki T; Akamatsu T; Tanaka J; Saga K; Nishio A; Honjo T; Chiba T
Gastroenterology; 2008 Oct; 135(4):1333-43. PubMed ID: 18651994
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ is reciprocally involved in the concurrent development of organ-specific autoimmunity in the liver and stomach.
Iwamoto S; Kido M; Aoki N; Nishiura H; Maruoka R; Ikeda A; Okazaki T; Chiba T; Watanabe N
Autoimmunity; 2012 Mar; 45(2):186-98. PubMed ID: 21995497
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice.
Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Tanaka J; Watanabe T; Tanaka Y; Okazaki T; Chiba T; Watanabe N
Gastroenterology; 2011 Apr; 140(4):1322-1333.e1-5. PubMed ID: 21237169
[TBL] [Abstract][Full Text] [Related]
5. TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression.
Iwamoto S; Kido M; Aoki N; Nishiura H; Maruoka R; Ikeda A; Okazaki T; Chiba T; Watanabe N
Clin Immunol; 2013 Jan; 146(1):15-25. PubMed ID: 23178752
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
7. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation.
Saeki C; Nakano M; Takahashi H; Saito S; Homma S; Tajiri H; Zeniya M
Clin Immunol; 2010 Apr; 135(1):156-66. PubMed ID: 20080065
[TBL] [Abstract][Full Text] [Related]
9. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
10. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
11. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
[TBL] [Abstract][Full Text] [Related]
13. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
Magnusen AF; Rani R; McKay MA; Hatton SL; Nyamajenjere TC; Magnusen DNA; Köhl J; Grabowski GA; Pandey MK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884512
[TBL] [Abstract][Full Text] [Related]
14. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
16. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
17. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
18. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
Front Immunol; 2018; 9():1090. PubMed ID: 29868034
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis.
Maruoka R; Aoki N; Kido M; Iwamoto S; Nishiura H; Ikeda A; Chiba T; Watanabe N
Gastroenterology; 2013 Jul; 145(1):209-220.e9. PubMed ID: 23523671
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]